# Jubilant Draximage Inc., dba Jubilant Radiopharma - Inspection Records

Source: https://www.keypedia.com/companies/jubilant-draximage-inc-dba-jubilant-radiopharma/107f9ed8-772f-43cd-98dc-3406bee2f884

> Inspection records and compliance data for Jubilant Draximage Inc., dba Jubilant Radiopharma in Kirkland, None. Access full analysis and detailed observations.

---

## Details

- Name: Jubilant Draximage Inc., dba Jubilant Radiopharma
- FEI Number: 3009003838
- City: Kirkland
- State: None
- Country Name: Canada
- Address Line 1: 16751 Rte Transcanadienne
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [Canada Inspection - Jubilant Draximage Inc., dba Jubilant Radiopharma - Inspection #85660 - 2025-01-13](https://www.keypedia.com/records/canada_inspection/jubilant-draximage-inc-dba-jubilant-radiopharma/a012fdbc-8c70-43d3-9641-ad9734911fdf) — source: Canada, date: January 13, 2025
- [FDA Inspection 1240367 - Jubilant Draximage Inc., dba Jubilant Radiopharma - 2024-04-23](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/54ee0de3-3111-4c44-84a9-488ea6c50f60) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 23, 2024
- [Canada Inspection - Jubilant Draximage Inc., dba Jubilant Radiopharma - Inspection #80238 - 2023-01-23](https://www.keypedia.com/records/canada_inspection/jubilant-draximage-inc-dba-jubilant-radiopharma/bbf6d88d-2365-4dcd-8e32-922c12c55c33) — source: Canada, date: January 23, 2023
- [FDA Inspection 1171562 - Jubilant Draximage Inc., dba Jubilant Radiopharma - 2022-06-10](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/9eec5bd4-8c1b-4c69-a412-0ff40462ae65) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 10, 2022
- [Canada Inspection - Jubilant Draximage Inc., dba Jubilant Radiopharma - Inspection #78702 - 2022-05-10](https://www.keypedia.com/records/canada_inspection/jubilant-draximage-inc-dba-jubilant-radiopharma/2151eaf7-d0fb-4720-80f3-27114e9b953b) — source: Canada, date: May 10, 2022
- [Canada Inspection - Jubilant Draximage Inc., dba Jubilant Radiopharma - Inspection #76050 - 2021-02-08](https://www.keypedia.com/records/canada_inspection/jubilant-draximage-inc-dba-jubilant-radiopharma/a9f4ca1e-2603-4515-b1e2-bb694a2813b8) — source: Canada, date: February 8, 2021
- [Canada Inspection - Jubilant Draximage Inc., dba Jubilant Radiopharma - Inspection #69864 - 2018-04-17](https://www.keypedia.com/records/canada_inspection/jubilant-draximage-inc-dba-jubilant-radiopharma/7f7f3e82-90d8-45f9-9fe9-61cd2e36cffd) — source: Canada, date: April 17, 2018
- [FDA Inspection 1035441 - Jubilant Draximage Inc., dba Jubilant Radiopharma - 2017-09-08](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/4abcfcd6-b3e3-4581-bd6d-6f34ab6c5056) — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2017
- [Canada Inspection - Jubilant Draximage Inc., dba Jubilant Radiopharma - Inspection #25521 - 2016-04-18](https://www.keypedia.com/records/canada_inspection/jubilant-draximage-inc-dba-jubilant-radiopharma/eb437a5e-093d-444c-afdc-65e253330063) — source: Canada, date: April 18, 2016
- [Canada Inspection - Jubilant Draximage Inc., dba Jubilant Radiopharma - Inspection #25341 - 2016-04-18](https://www.keypedia.com/records/canada_inspection/jubilant-draximage-inc-dba-jubilant-radiopharma/657449fe-f2c9-4701-a4aa-05728db58c40) — source: Canada, date: April 18, 2016
- [FDA Inspection 953137 - Jubilant Draximage Inc., dba Jubilant Radiopharma - 2015-12-17](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/23ad4614-9e19-4ea5-98ac-2bc03b0981ad) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 17, 2015
- [FDA Inspection 850564 - Jubilant Draximage Inc., dba Jubilant Radiopharma - 2013-09-17](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/7acce93f-cf78-4659-9616-730f5c9d0935) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 17, 2013

## Related Companies

- [Patheon Inc.](https://www.keypedia.com/companies/patheon-inc/5aa1b743-e01d-49ef-afca-c234bb7fa32b)
- [BWXT Medical Ltd](https://www.keypedia.com/companies/bwxt-medical-ltd/020d2f7a-bcde-4c0d-ade0-6aaf88ce6110)
- [Laboratoires KABS Inc.](https://www.keypedia.com/companies/laboratoires-kabs-inc/f64238f5-ac9f-48fe-a653-86a4cdcb1dbc)
- [Bausch Health Companies Inc.](https://www.keypedia.com/companies/bausch-health-companies-inc/3190f4ed-695e-491f-a57e-1ef128f7e2af)
- [Voyant Beauty, Inc.](https://www.keypedia.com/companies/voyant-beauty-inc/881e2944-36f2-4984-9ca9-319b61788b64)
- [Taro Pharmaceuticals Inc.](https://www.keypedia.com/companies/taro-pharmaceuticals-inc/2072a3d5-a0ae-4bb7-9375-a6406a4fd768)
- [Vetoquinol N.-A.](https://www.keypedia.com/companies/vetoquinol-n-a/49dc7657-0eb1-4108-a582-681d3714d198)
- [HK Kolmar Canada, Inc.](https://www.keypedia.com/companies/hk-kolmar-canada-inc/93c7059a-6f10-4fed-ad4f-e06974af950b)
- [Lernapharm (Loris) Inc.](https://www.keypedia.com/companies/lernapharm-loris-inc/2321aaaa-6f7e-4dc9-9c7e-09593fa9efda)
- [Diversey Canada, Inc.](https://www.keypedia.com/companies/diversey-canada-inc/08a08842-7884-4417-bc84-a625d0dae16d)